Luxturna 5000000000000 Vg

Voretigene neparvovec, the active ingredient in Luxturna 5000000000000 Vg, is a gene therapy presented as a 5,000,000,000,000 vg solution for subretinal use. It is indicated for the treatment of vision loss due to inherited retinal dystrophy caused by mutations in the RPE65 gene in adults and children. GNH USA supplies Luxturna 5000000000000 Vg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Luxturna is a groundbreaking gene therapy designed to address genetic disorders affecting vision. It is specifically formulated to deliver a functional copy of the RPE65 gene to retinal cells, thereby restoring vision in patients with specific genetic mutations.

Luxturna is used in the treatment of inherited retinal dystrophy caused by mutations in the RPE65 gene. This condition leads to progressive vision loss and, in many cases, blindness. The therapy is designed to deliver a functional copy of the RPE65 gene to retinal cells, thereby restoring vision.

- RPE65-mediated inherited retinal dystrophy: Restores vision in patients with this genetic condition. - Biallelic RPE65 mutation-associated retinal dystrophy: Improves visual function and potentially slows further vision loss. - Leber congenital amaurosis type 2: Enhances visual cycle and improves visual acuity.

Luxturna may cause several side effects, ranging from common to serious. It is important to be aware of these potential effects and to consult with a healthcare provider if any adverse reactions occur.

Common Side Effects: - Redness of the eye - Eye swelling or pain - Clouding of the lens of the eye (cataract) - Increased pressure inside the eye - Eye infections - Retinal detachment - Bleeding in the retina - Permanent decline in the sharpness of your vision - Thinning of the retina or loss of function - Breaks or wrinkling on the surface of your retina - Deposits under your retina - Thinning of the clear layer in front of your eye - New or worsening cataract

Luxturna should be used with caution and under the supervision of a healthcare provider. Certain precautions and warnings should be observed to ensure safe and effective use.

- Avoid air travel or other travel to high elevations: Until advised by your doctor, as the air bubble inserted during treatment may expand and lead to eye damage. - Follow-up visits: Important to return for follow-up visits to identify and treat any side effects. - Eye surgery: Required before receiving Luxturna, which may lead to complications such as cataracts. - Subretinal injection: Should not be administered in the immediate vicinity of the fovea to maintain foveal integrity. - Store at ≤-65 ºC: Once thawed, the medicine should not be re-frozen and should be left at room temperature (below 25 °C).

Luxturna may interact with other medications or conditions, which can affect its efficacy or increase the risk of side effects. It is important to discuss all current medications and health conditions with a healthcare provider before starting Luxturna.

Major Interactions (Avoid): - None identified Moderate Interactions (Monitor Closely): - None identified